期刊文献+

乳腺癌组织中Nup88、PINCH mRNA表达与HER-2的相关性研究 被引量:2

下载PDF
导出
摘要 目的探讨乳腺癌组织中Nup88、PINCH mRNA表达与HER-2的关系。方法利用RT-PCR方法检测Nup88、PINCH mRNA在40例乳腺癌组织中的表达水平,并进一步用Spearman法对Nup88、PINCH mRNA表达和HER-2进行相关性分析。结果 Nup88 mRNA在乳腺癌组织中的表达水平为0.575±0.230,PINCH mRNA在乳腺癌组织中的表达水平为0.875±0.470;HER-2蛋白表达为:(-)20例,(+)8例,(++)5例,(+++)7例。Nup88 mRNA表达与HER-2相关性无统计学意义,但具有正相关趋势,r=0.30、P=0.062;PINCH mRNA表达与HER-2相关性亦无统计学意义,但具有正相关趋势,r=0.31、P=0.054。结论 Nup88、PINCH mRNA与HER-2可能在乳腺癌的发生、发展、转移过程中发挥一定的协同作用。
出处 《山东医药》 CAS 2012年第40期40-42,共3页 Shandong Medical Journal
基金 河北省科技攻关计划项目(10276105D-71)
  • 相关文献

参考文献18

  • 1Higgins MJ, Baselga J. Targeted therapies for breast cancer [ J]. J Clin Invest, 2011 , 121 (10) :3797-3803.
  • 2Gould VE, Martinez N, Orucevic A, et al. A novel, nuclear pore- associated, widely distributed molecule overexpressed in oncogenesis and development [ J ]. Am J Pathol, 2000,157 ( 5 ) : 1605-1613.
  • 3Wang-Rodriguez J, Dreilinger AD, Alsharabi GM, et al. The signa- ling adapter protein PINCH is up-regulated in the stroma of common cancers, notably at invasive edges [ J ]. Cancer, 2002,95 ( 6 ) : 1387-1395.
  • 4Gajria D, Chandarlapaty S. HER2-amplified breast cancer: mecha- nisms of trastuzumab resistance and novel targeted therapies [ J ]. Expert Rev Anticancer Ther, 2011,11 (2) :263-275.
  • 5王佳玉,徐兵河.HER-2和Top-Ⅱα可作为乳腺癌化疗疗效的预测因子[J].临床药物治疗杂志,2011,9(2):45-49. 被引量:3
  • 6吴美华,冯震博.乳腺癌中HER-2、P16和P53的表达及预后意义[J].当代医学,2011,17(9):15-17. 被引量:7
  • 7武露艳,姜秋颖,李里,信涛,黄大勇.VES对Her-2、p53共表达乳腺癌细胞的抑制作用及机制[J].现代肿瘤医学,2011,19(4):645-649. 被引量:2
  • 8王佳妮,刘仁斌,梁惠珍,周兴华,王深明.乳腺癌组织中HER2、ERα、ERβ、PR的表达及其相关性分析[J].中华普通外科学文献(电子版),2008,2(6):34-37. 被引量:14
  • 9Xu S, Powers MA. Nuclear pore proteins and cancer [ J ]. Semin Cell Dev Biol, 2009,20 ( 5 ) : 620 -630.
  • 10Hashizume C, Nakano H, Yoshida K, et al. Characterization of the role of the tumor marker Nup88 in mitosis [ J ]. Mol Cancer, 2010,(9) :119.

二级参考文献69

  • 1Kun Wu1,Yu Juan Shan1,Yan Zhao1,Jian Wu Yu2,Bai He Liu1 1Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, Harbin 150001, Heilongjiang Province, China2The Second Affiliated Hospital, Harbin Medical University, Harbin 150001, Heilongjiang Province, China.Inhibitory effects of RRR-α-tocopheryl succinate on benzo (a) pyrene (B (a) P)-induced forestomach carcinogenesis in female mice[J].World Journal of Gastroenterology,2001,7(1):60-65. 被引量:24
  • 2郑莉,任加强,张琳,陈琦,朱虹光.乳腺癌细胞过表达HER2/neu时经PI3K和Ras/Raf/MEK/ERK信号通路下调野生型p53蛋白含量[J].中华病理学杂志,2004,33(4):358-362. 被引量:8
  • 3Cooke T,Eeeves J,Lanigan A,et aI.HEP,2 as a prognostic and predictive marker for breast cancer[J].Ann 0ncol,200],12(1):25-28.
  • 4Kamil M,Yusuf N,Kh&lid I,et al.Associ&tion between HER-2/ neu over expression and clinico pathologic parameterg of breast cancer in northern Malaysia[J].Oeylon Med J,20]0,55(1):9 13.
  • 5Toikkanen S,Helin H,Isola J,et aI.Prognostic significance ofHER-2 oncoprotein expression in bre&st c&ncer:& 50--ye&r follow--up[J].JClin Oncol,1992, 1 0(7):1044-1048.
  • 6Strauss B Best hope or last hope: access to phase Ill clinicaltrials of HER-2/neu for advanced stage breast cancer patients[J].J AdvNurs,2000,51(2):259 266.
  • 7Borg A,andon A K,Sigurdsson H,et aI.HEE--2/neu ampiificationpredicts poor survival in node-posftive breast cancer[J].C&ncerEes.1990.50(14).4552-4557.
  • 8Ohtani N,Yamakoshi K,Takahashi A,et al.The pl61NK4a-RB pathway:molecular link between cellular senescence and tumor suppression[J]. J Med Invest,2004,51(5 4):146-155.
  • 9Tsuda H,Yamamoto K,Inoue T, et al.The role of pl6--cyclin d/ CPK--pRb pathway in the tumorigenesis of endometrioid type endornetrial carcinorna[J].Br J Cancer,2000,82(5):675-682.
  • 10Merlo A,Herman J O Mao L,et &l. 5' CpG island methyIation is associated with transcrfptionsl silencing of the tumour suppressor p16/ CDKN2/MTS1 in human cancers[J].Nat Med,1995,1(7):686-692.

共引文献23

同被引文献19

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部